Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

OBIORA M EKWEANI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1780670315
CMS profile
353460
Location
FRISCO, TX

General Payments · PY2018–2024

$5,297.87

  • Reported across 274 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$748.78

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $748.78 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $173.79 8
Indivior Inc. $171.46 8
Acerta Pharma LLC $108.86 6
ABBVIE INC. $71.37 3
Amgen Inc. $71.14 4
Lilly USA, LLC $36.85 2
Exact Sciences Corporation $34.19 1
Novo Nordisk AS $31.62 2
GlaxoSmithKline, LLC. $26.48 1
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $614.03 42
PY2019 $162.60 11
PY2020 $534.36 34
PY2021 $1,100.52 56
PY2022 $1,181.17 43
PY2023 $956.41 52
PY2024 $748.78 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.22 03/18/2024 Food and Beverage Undisputed 01/23/2026 1103682421 CMS
ABBVIE INC. $28.40 05/16/2024 Food and Beverage Undisputed 01/23/2026 1103682423 CMS
ABBVIE INC. $26.75 07/12/2024 Food and Beverage Undisputed 01/23/2026 1103682425 CMS
Amgen Inc. $23.66 02/01/2024 Food and Beverage Undisputed 01/23/2026 1117547803 CMS
Amgen Inc. $19.27 06/25/2024 Food and Beverage Undisputed 01/23/2026 1117547805 CMS
Amgen Inc. $14.03 08/08/2024 Food and Beverage Undisputed 01/23/2026 1115598249 CMS
Amgen Inc. $14.18 11/06/2024 Food and Beverage Undisputed 01/23/2026 1117547807 CMS
AstraZeneca Pharmaceuticals LP $22.18 04/01/2024 Food and Beverage Undisputed 01/23/2026 1104383575 CMS
AstraZeneca Pharmaceuticals LP $20.19 04/03/2024 Food and Beverage Undisputed 01/23/2026 1104345112 CMS
AstraZeneca Pharmaceuticals LP $14.91 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105858254 CMS
AstraZeneca Pharmaceuticals LP $19.67 04/29/2024 Food and Beverage Undisputed 01/23/2026 1104386313 CMS
AstraZeneca Pharmaceuticals LP $15.15 08/28/2024 Food and Beverage Undisputed 01/23/2026 1104715579 CMS
AstraZeneca Pharmaceuticals LP $16.76 10/21/2024 Food and Beverage Undisputed 01/23/2026 1105607087 CMS
Exact Sciences Corporation $34.19 12/03/2024 Food and Beverage Undisputed 01/23/2026 1114646619 CMS
GlaxoSmithKline, LLC. $26.48 02/27/2024 Food and Beverage Undisputed 01/23/2026 1116721251 CMS
Indivior Inc. $22.87 02/07/2024 Food and Beverage Undisputed 01/23/2026 1144527214 CMS
Indivior Inc. $18.81 03/13/2024 Food and Beverage Undisputed 01/23/2026 1144527216 CMS
Indivior Inc. $33.81 07/08/2024 Food and Beverage Undisputed 01/23/2026 1144527218 CMS
Indivior Inc. $19.06 07/26/2024 Food and Beverage Undisputed 01/23/2026 1144527220 CMS
Indivior Inc. $18.28 08/20/2024 Food and Beverage Undisputed 01/23/2026 1144527222 CMS
Indivior Inc. $18.80 09/17/2024 Food and Beverage Undisputed 01/23/2026 1144527224 CMS
Indivior Inc. $24.01 10/14/2024 Food and Beverage Undisputed 01/23/2026 1144527226 CMS
Indivior Inc. $15.82 12/13/2024 Food and Beverage Undisputed 01/23/2026 1144527228 CMS
Lilly USA, LLC $18.15 01/20/2024 Food and Beverage Undisputed 01/23/2026 1135295901 CMS
Lilly USA, LLC $18.70 07/15/2024 Food and Beverage Undisputed 01/23/2026 1135295905 CMS
Novo Nordisk Inc $15.08 03/20/2024 Food and Beverage Undisputed 01/23/2026 1097765361 CMS
Novo Nordisk Inc $16.54 05/13/2024 Food and Beverage Undisputed 01/23/2026 1096959444 CMS
PFIZER INC. $26.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 1131016257 CMS
PFIZER INC. $14.18 03/06/2024 Food and Beverage Undisputed 01/23/2026 1131119753 CMS
PFIZER INC. $35.97 04/06/2024 Food and Beverage Undisputed 01/23/2026 1131419341 CMS
PFIZER INC. $27.10 04/10/2024 Food and Beverage Undisputed 01/23/2026 1131353737 CMS
PFIZER INC. $19.92 05/09/2024 Food and Beverage Undisputed 01/23/2026 1131473727 CMS
PFIZER INC. $13.60 06/11/2024 Food and Beverage Undisputed 01/23/2026 1131443193 CMS
PFIZER INC. $17.73 07/12/2024 Food and Beverage Undisputed 01/23/2026 1131633334 CMS
PFIZER INC. $19.29 07/16/2024 Food and Beverage Undisputed 01/23/2026 1131743364 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.02 07/03/2024 Food and Beverage Undisputed 01/23/2026 1153656519 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.